Het Jessa Ziekenhuis is een regionaal ziekenhuis in de Belgische stad Hasselt. Met zijn 988 erkende bedden is het Jessa Ziekenhuis het op vier na grootste ziekenhuis in Vlaanderen. Het telt drie campussen: campus Virga Jesse aan de Stadsomvaart, campus Salvator in Hasselt en campus Sint-Ursula in Herk-de-Stad.

During the past decade, Jessa Ziekenhuis conducted 143 clinical trials. In the 10-year time frame, 143 clinical trials started and 42 clinical trials were completed, i.e. on average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 55 clinical trials started and 22 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jessa Ziekenhuis" #1 sponsor was "Hasselt University" with 33 trials, followed by "Hoffmann-La Roche" with 20 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 7 trials sponsored, "Janssen Research & Development, LLC" with 7 trials sponsored and "Boehringer Ingelheim" with 7 trials sponsored. Other sponsors include 123 different institutions and companies that sponsored additional 84 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jessa Ziekenhuis" #1 collaborator was "Jessa Hospital" with 31 trials as a collaborator, "Ziekenhuis Oost-Limburg" with 8 trials as a collaborator, "KU Leuven" with 5 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator and "Bristol-Myers Squibb" with 3 trials as a collaborator. Other collaborators include 96 different institutions and companies that were collaborators in the rest 94 trials.

According to Clinical.Site data, the most researched conditions in "Jessa Ziekenhuis" are "Breast Cancer" (13 trials), "Atrial Fibrillation" (9 trials), "Coronary Artery Disease" (9 trials), "Prostate Cancer" (8 trials) and "Alzheimer Disease" (5 trials). Many other conditions were trialed in "Jessa Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Jessa Ziekenhuis" are "Drug" (108 trials), "Other" (37 trials), "Device" (31 trials), "Procedure" (17 trials) and "Diagnostic Test" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Carboplatin" (7 trials), "Paclitaxel" (7 trials), "Atezolizumab" (5 trials) and "Trastuzumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Jessa Ziekenhuis" are 179 trials for "All" genders, 13 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Jessa Ziekenhuis". undefined are not yet recruiting, 39 are recruiting, 21 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 101 completed trials in Jessa Ziekenhuis, 1 suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Jessa Ziekenhuis, 6 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 71 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 54 trials that are defined as “Not Applicable".